Cargando…
Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure
PURPOSE: Following the first wave of the COVID-19 pandemic in early 2020, the easing of strict measures to reduce its spread has led to a resurgence of cases in many countries at both the national and local level. This article addresses how guidance for ophthalmologists on managing patients with ret...
Autores principales: | Korobelnik, Jean-François, Loewenstein, Anat, Eldem, Bora, Joussen, Antonia M., Koh, Adrian, Lambrou, George N., Lanzetta, Paolo, Li, Xiaoxin, Lövestam-Adrian, Monica, Navarro, Rafael, Okada, Annabelle A., Pearce, Ian, Rodríguez, Francisco J., Wong, David T., Wu, Lihteh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852054/ https://www.ncbi.nlm.nih.gov/pubmed/33528647 http://dx.doi.org/10.1007/s00417-021-05097-0 |
Ejemplares similares
-
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
por: Korobelnik, Jean-François, et al.
Publicado: (2020) -
CURRENT CONCEPTS AND MODALITIES FOR MONITORING THE FELLOW EYE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: An Expert Panel Consensus
por: Wong, Tien Yin, et al.
Publicado: (2020) -
Communicating with patients requiring anti-VEGF intravitreal injections and their families during the COVID-19 pandemic: an update
por: Korobelnik, Jean-François, et al.
Publicado: (2021) -
Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases
por: Lanzetta, Paolo, et al.
Publicado: (2017) -
SUSPENDING TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN CASES OF FUTILITY
por: Wong, David T., et al.
Publicado: (2020)